Johnson & Johnson Office of the Chief Medical Officer (OCMO) Women’s Health team, together with Johnson & Johnson Innovation - JLABS, is proud to introduce the Maternal Health QuickFire Challenge.
Visionaries are invited to submit ideas aiming to improve pregnancy, birth, and postpartum care for women, making birth safer in the United States and potentially changing the trajectory of health for a lifetime.
The innovator(s) with the best idea, potential technology, or potential solution will receive up to $200,000 in grant funding, access to the global JLABS network and mentorship from experts at the Johnson & Johnson Family of Companies.
Apply at jlabs.tv/maternal by June 19, 2020.
About Johnson & Johnson Office of the Chief Medical Officer
The Johnson & Johnson Office of the Chief Medical Officer (OCMO) is an internal global team of medical and scientific professionals, including safety experts, from all three sectors of Johnson & Johnson. Functionally independent from commercial or R&D interests, the OCMO is focused on the safety of products through people-driven processes, initiatives and policies that are reinforced by a single medical safety standard. Established in 2013, the OCMO also works to advance evidence and science-based decision-making that is driven by bioethical principles and values.
About Johnson & Johnson Innovation
Johnson & Johnson Innovation LLC focuses on accelerating all stages of innovation worldwide and forming collaborations between entrepreneurs and Johnson & Johnson’s global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies with one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and consumer companies of Johnson & Johnson. Under the Johnson & Johnson Innovation umbrella of businesses, we connect with innovators through our regional Innovation Centers; Johnson & Johnson Innovation - JLABS; JJDC, Inc.; and our business development teams to create customized deals and novel collaborations that speed development of innovations to solve unmet needs in patients. JLABS provides the laboratories, expertise, education, tools and resources needed to help life science startups thrive, all with no strings attached. A Johnson & Johnson Innovation Center for Device Innovation at the Texas Medical Center (CDI @ TMC) has been established to accelerate the development of medical devices. For more information about Johnson & Johnson Innovation, please visit: www.jnjinnovation.com .
About Johnson & Johnson Innovation - JLABS
Johnson & Johnson Innovation – JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators across a broad healthcare spectrum including pharmaceutical, medical device, consumer and health tech sectors to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS, we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS also produces campaigns to seek out the best science called QuickFire Challenges. For more information, visit www.jlabs.jnjinnovation.com or follow @JLABS.